A pediatric case series of invasive pneumococcal disease caused by S.Pneumonia serotype-19A despite full dose vaccination
- PMID: 37334472
- PMCID: PMC10332181
- DOI: 10.1080/21645515.2023.2219186
A pediatric case series of invasive pneumococcal disease caused by S.Pneumonia serotype-19A despite full dose vaccination
Abstract
Streptococcus pneumoniae is the leading cause of community-acquired pneumonia and bacterial meningitis in children. Although pneumococcal conjugate vaccines (PCVs) are commonly available, invasive pneumococcal disease (IPD) still remains a life-threatening complication. Serotype 19A has high invasive potential and is capable of causing extensive and destructive lung disease. This strain has greater invasive potential, may have a growth advantage over other pneumococcal serotypes in normally sterile sites, and is often resistant to multiple antibiotics. Although being a component of PCV13 vaccine, serotype 19A may still be seen in fully vaccinated children and can cause invasive disease. Herein, we present four cases of IPD caused by S. pneumoniae serotype 19A who received the full regimen of PCV13 vaccination.
Keywords: Pneumococci serotype 19; invasive pneumococcal disease; pediatric.
Conflict of interest statement
No potential conflict of interest was reported by the author(s).
Similar articles
-
Streptococcus pneumoniae serotype 19A in hospitalized children with invasive pneumococcal disease after the introduction of conjugated vaccines in Lima, Peru.J Infect Public Health. 2024 Jan;17(1):44-50. doi: 10.1016/j.jiph.2023.10.047. Epub 2023 Nov 2. J Infect Public Health. 2024. PMID: 37992433
-
CIRCULATING CLONAL COMPLEXES AND SEQUENCE TYPES OF STREPTOCOCCUS PNEUMONIAE SEROTYPE 19A WORLDWIDE: THE IMPORTANCE OF MULTIDRUG RESISTANCE: A SYSTEMATIC LITERATURE REVIEW.Expert Rev Vaccines. 2021 Jan;20(1):45-57. doi: 10.1080/14760584.2021.1873136. Epub 2021 Feb 17. Expert Rev Vaccines. 2021. PMID: 33507135
-
Effectiveness of Pneumococcal Conjugate Vaccines Against Community-acquired Alveolar Pneumonia Attributable to Vaccine-serotype Streptococcus pneumoniae Among Children.Clin Infect Dis. 2021 Oct 5;73(7):e1423-e1433. doi: 10.1093/cid/ciaa1860. Clin Infect Dis. 2021. PMID: 33346348 Free PMC article.
-
Effectiveness of 10 and 13-valent pneumococcal conjugate vaccines against invasive pneumococcal disease in European children: SpIDnet observational multicentre study.Vaccine. 2022 Jun 23;40(29):3963-3974. doi: 10.1016/j.vaccine.2022.05.011. Epub 2022 May 28. Vaccine. 2022. PMID: 35637067
-
Streptococcus pneumoniae serotype 19A: worldwide epidemiology.Expert Rev Vaccines. 2017 Oct;16(10):1007-1027. doi: 10.1080/14760584.2017.1362339. Epub 2017 Aug 28. Expert Rev Vaccines. 2017. PMID: 28783380 Review.
References
-
- Lee HY, Hsieh YC, Liu CC, Huang YC, Chang KY, Chi H, Chang LY, Huang YC, Huang LM. Taiwan pediatric infectious diseases alliance. Invasive pneumococcal pneumonia caused by 13-valent pneumococcal conjugate vaccine types in children with different schedules. J Microbiol Immunol Infect. 2018. Apr;51(2):199–206. doi:10.1016/j.jmii.2017.08.022. Epub 2017 Sep 27. PMID: 29021105. - DOI - PubMed
-
- Olarte L, Barson WJ, Barson RM, Lin PL, Romero JR, Tan TQ, Givner LB, Bradley JS, Hoffman JA, Hultén KG, et al. Impact of the 13-valent pneumococcal conjugate vaccine on pneumococcal meningitis in US children. Clin Infect Dis. 2015. Sep 1;61(5):767–75. doi:10.1093/cid/civ368. Epub 2015 May 13. PMID: 25972022. - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical